|
FAM117B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.02609999999859E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.69659999999161E-06 |
| Normal-vs-Stage2 |
4.637600E-03 |
| Normal-vs-Stage3 |
2.575100E-03 |
| Normal-vs-Stage4 |
1.089620E-02 |
| Stage1-vs-Stage2 |
7.259000E-01 |
| Stage1-vs-Stage3 |
7.646200E-01 |
| Stage1-vs-Stage4 |
7.908200E-01 |
| Stage2-vs-Stage3 |
9.376400E-01 |
| Stage2-vs-Stage4 |
9.979200E-01 |
| Stage3-vs-Stage4 |
9.457200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.14109999999912E-05 |
| Normal-vs-AfricanAmerican |
1.298560E-03 |
| Normal-vs-Asian |
3.615900E-03 |
| Caucasian-vs-AfricanAmerican |
7.579800E-01 |
| Caucasian-vs-Asian |
5.202600E-01 |
| AfricanAmerican-vs-Asian |
4.226200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34809999996488E-06 |
| Normal-vs-Female |
1.125430E-01 |
| Male-vs-Female |
9.102900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.991060E-04 |
| Normal-vs-Extreme_Weight |
1.57906000000096E-05 |
| Normal-vs-Obese |
5.805500E-04 |
| Normal-vs-Extreme_Obese |
2.230600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.775000E-01 |
| Normal_Weight-vs-Obese |
4.925200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.129600E-01 |
| Extreme_Weight-vs-Obese |
2.894600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.535800E-01 |
| Obese-vs-Extreme_Obese |
8.084000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.911900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.943300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.5789999999738E-06 |
| Normal-vs-Age(81-100Yrs) |
5.755800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.982200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.529500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.332200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.069700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.185600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.694000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.401220E-04 |
| Normal-VS-Type2 PRCC |
8.15269999954182E-07 |
| Normal-VS-KIRP CIMP |
1.438840E-01 |
| Normal-VS-Unclassified PRCC |
3.883900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.072200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.736800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.220200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.125050E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.736100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.778200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.92340000487934E-08 |
| Normal-vs-N1 |
8.020200E-01 |
| Normal-vs-N2 |
8.504000E-01 |
| N0-vs-N1 |
1.495690E-02 |
| N0-vs-N2 |
1.365670E-02 |
| N1-vs-N2 |
9.894000E-01 |
|
|
